Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Planer is a UK-based life science and reproductive health equipment company focused on controlled-rate freezing, embryo incubation, alarm and monitoring systems, cryogenic storage, and laboratory traceability tools for IVF, assisted reproductive technology, cell biology, and biobanking workflows. Founded in 1973, the company supplies hospitals, laboratories, pharmaceutical companies, IVF clinics, and research organizations with hardware, software, and integrated systems used to preserve, store, monitor, and handle sensitive biological specimens. Its portfolio includes cryogenic freezers, benchtop incubators, monitoring solutions, cryogenic storage systems, and witness/traceability systems designed to support compliance and sample integrity. Planer operates as a commercial medical device and laboratory equipment business rather than a therapeutic drug developer. The company was acquired by Hamilton Thorne in August 2019 and is now presented as part of the broader Nexpring Health group brand architecture.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Planer.